These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 2894995)
41. Immunoregulatory function of CD3+, CD4-, and CD8- T cells. Gamma delta T cell receptor-positive T cells from nude mice abrogate oral tolerance. Fujihashi K; Kiyono H; Aicher WK; Green DR; Singh B; Eldridge JH; McGhee JR J Immunol; 1989 Dec; 143(11):3415-22. PubMed ID: 2573632 [TBL] [Abstract][Full Text] [Related]
42. Subpopulations of mouse Lyt-2+ T cells defined by the expression of an Ly-6-linked antigen, B4B2. Fichtner AT; Anderson S; Mage MG; Sharrow SO; Thomas CA; Kung JT J Immunol; 1987 Apr; 138(7):2024-33. PubMed ID: 2435788 [TBL] [Abstract][Full Text] [Related]
43. Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones. Parkman R J Immunol; 1986 May; 136(10):3543-8. PubMed ID: 2871104 [TBL] [Abstract][Full Text] [Related]
44. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. Via CS; Sharrow SO; Shearer GM J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440 [TBL] [Abstract][Full Text] [Related]
45. Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcoma. Sakai K; Chang AE; Shu SY Cancer Res; 1990 Jul; 50(14):4371-6. PubMed ID: 2114215 [TBL] [Abstract][Full Text] [Related]
46. Antigen-presenting cells for Lyt-2+ cells. I. Stimulation of unprimed Lyt-2+ cells by H-2 different Thy-1-Ia- cells prepared from spleen and bone marrow. Sprent J; Schaefer M J Immunol; 1988 Jun; 140(11):3745-50. PubMed ID: 2897393 [TBL] [Abstract][Full Text] [Related]
47. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis. Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421 [TBL] [Abstract][Full Text] [Related]
48. Modulation of lymphocyte subsets in Peyer's patches of mice treated with monoclonal antibody against helper T-cells. Ermak TH; Steger HJ; Owen RL; Heyworth MF J Histochem Cytochem; 1988 Apr; 36(4):417-23. PubMed ID: 2964470 [TBL] [Abstract][Full Text] [Related]
49. Immunoglobulin-dependent helper T cells: studies in the MOPC-315 system suggest a novel surface antigen phenotype. Rohrer JW; Kemp JD J Immunol; 1986 Sep; 137(6):1786-92. PubMed ID: 2943802 [TBL] [Abstract][Full Text] [Related]
50. Class-specific regulation of anti-DNA antibody synthesis and the age-associated changes in (NZB x NZW)F1 hybrid mice. Sekigawa I; Okada T; Noguchi K; Ueda G; Hirose S; Sato H; Shirai T J Immunol; 1987 May; 138(9):2890-5. PubMed ID: 2952727 [TBL] [Abstract][Full Text] [Related]
51. Selective up-regulation by interferon-gamma of surface molecules of the Ly-6 complex in resting T cells: the Ly-6A/E and TAP antigens are preferentially enhanced. Dumont FJ; Dijkmans R; Palfree RG; Boltz RD; Coker L Eur J Immunol; 1987 Aug; 17(8):1183-91. PubMed ID: 3040423 [TBL] [Abstract][Full Text] [Related]
52. Cellular origins and target cells of immunoregulatory factors in mice with disseminated histoplasmosis. Deepe GS; Watson SR; Bullock WE J Immunol; 1984 Apr; 132(4):2064-71. PubMed ID: 6230399 [TBL] [Abstract][Full Text] [Related]
53. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. Titus RG; Ceredig R; Cerottini JC; Louis JA J Immunol; 1985 Sep; 135(3):2108-14. PubMed ID: 3926895 [TBL] [Abstract][Full Text] [Related]
54. T cell subsets and IFN-gamma production in resistance to systemic candidosis in immunized mice. Cenci E; Romani L; Vecchiarelli A; Puccetti P; Bistoni F J Immunol; 1990 Jun; 144(11):4333-9. PubMed ID: 1971296 [TBL] [Abstract][Full Text] [Related]
55. Phenotypic characteristics of cells involved in induced suppression to murine experimental autoimmune thyroiditis. Parish NM; Roitt IM; Cooke A Eur J Immunol; 1988 Sep; 18(9):1463-7. PubMed ID: 2971553 [TBL] [Abstract][Full Text] [Related]
56. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential. Boswell HS; Wade PM; Quesenberry PJ J Immunol; 1984 Dec; 133(6):2940-9. PubMed ID: 6149245 [TBL] [Abstract][Full Text] [Related]
57. In-vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. I. Effect of anti-Thy-1 antibody on the tissue distribution of lymphocytes. Le Gros GS; Prestidge RL; Watson JD Immunology; 1983 Dec; 50(4):537-46. PubMed ID: 6606612 [TBL] [Abstract][Full Text] [Related]
58. Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells. Gutstein NL; Wofsy D J Immunol; 1986 Dec; 137(11):3414-9. PubMed ID: 3097122 [TBL] [Abstract][Full Text] [Related]
59. Subpopulations of CD4- CD8- murine thymocytes: differences in proliferation rate in vivo and proliferative responses in vitro. Ewing T; Egerton M; Wilson A; Scollay R; Shortman K Eur J Immunol; 1988 Feb; 18(2):261-8. PubMed ID: 2894996 [TBL] [Abstract][Full Text] [Related]
60. Prevention of lymphadenopathy in MRL-lpr/lpr mice by blocking peripheral lymph node homing with Mel-14 in vivo. Mountz JD; Gause WC; Finkelman FD; Steinberg AD J Immunol; 1988 May; 140(9):2943-9. PubMed ID: 2834447 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]